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Two P388 cell sublines with different lovels of resistance to daunomycin (DNM). P388/20 and P3881100 cells (-- ZO- and IOO-fold resistance, 
respcctivcly), undergo a significant (- Z-fold) increase in the number of intramcmbrune particles (IMPS) present at their plasma membrane, as 
compared to that exhibited by the parental, drug-scnsitivc 1’388 (P38WS) cell line. Regardless of the IWCI of resistance, incubation ofdrug-resistant 
cells with vcmpamil. a wzll known reverting agent of nntbracycline resistance, restores the morphology of the plasma membrane in these cells, 
yielding a pattern in which the number and size distribution of IMPs at both lenflcts of the bilayer, become undistinguishable from those displayed 
by drug-sensitive cells. Furthermore, vcrnpamil did not affLrt the ultrnstructural orpanizdtion of the plasma membrane ofdru&-sensitive cells. It 
is possible that the alterations in the structural organization of the plasma membrane of the antineoplastic-resistant tumor cells, might represent 
a reliable ‘marker’ fcr early diagnosis of drug resistance. 
Ccllulur drug msistancc; Verapamil; Intramembranc parlicle; Freeze-fracture 
1. INTRODUCTION 
The acquisition of the multidrug resistance pheno- 
type (MDR) by tumor cells involves a pleitropic re- 
sponse which include alterations in the molecular com- 
ponents [ I,23 as well as in the dynamic properties [3] of 
the cell membrane. In molecular terms, the best known 
and widely spread change associated with MDR is rep- 
resented by the overexpression of P-glycoprotein, a 
plasma membrane protein [4], which acts as an ATP- 
dependent efflux pump able to eliminate drugs and lipo- 
philic substances from the cells [5,6]. The reduced drug 
accumulation observed in drug-resistant cells, can be 
abolished by several agents including calcium channel 
blockers, calmodulin inhibitors, etc.. These compounds 
increase intracellular drug levels presumably by inter- 
fering with anti-neoplastic binding and transport by D- 
glycoprotein I?$]. 
volved in the development of MDR [9,10], few studies 
have been devoted to analyze the incidence of acquiring 
the resistant phenotype on the ultrastructural organiza- 
tion of these membranes [l l-141. Nevertheless, Ar- 
senault et al. [12] using drug-resistant Chinese hamster 
ovary (CHO) cells and human leukemia cells, Garcia- 
Segura et al. [L3] using daunomycin (DNM)-resistant 
P388 cells and Sehested et al.[14] working on Ehrlich 
ascites tumor cells, coincide in that acquisition of drug 
resistance is associated to a pronounced increase in the 
number of intramembrane particles (IMPS) at the 
plasma membranes of these cells. In order to further 
explore the relevance of these alterations to the MDR 
phenotype, we have analyzed the influence of the resis- 
tance-reverting agent verapamil (VRP), on the struc- 
tural organization of the plasma membranes from two 
P388 cell sublines increasingly resistant o DNM. 
In spite of the fact that the plasma membrane of 
tumor cells appears as a cellular structure critically in- 2. MATERlAES AND METHODS 
Corre~por~derrce a ldress: J.A. Fcrragut, Department of Neurochcmis- 
irj i,iIJ Institute of Neurosciences, University of Alicante. 03080 Ali- 
cnntc. Spain. Fax: (34) (G) 565 8557. 
Abbrcviurions: DNM. daunomycin; VRP. vcrapamil; IMPS, intra- 
membrane particles; P38S/S, DNM-sensitive P388 cells; P385/20. 
- 20- fold DNM-resistant P388 cells; P3881100, - 100.fold DNM- 
resistant P388 ceils; MDR. celiuinr muhidrug rcsistancc; CHG. Chi- 
nest hamster ovary cells; P and E leaf&, protoplasmic and exoplas- 
mic leuflets of the plasma membrane, respectively. 
Parental DNM-scnsitivc 1’388 murine leukemia cells (P3WS) and 
LWO cell sublines selected for resistance to DNM (- 20- and - 100” 
fold resistance. respcTtively), were maintained in culture as describd 
previously [I]. The level of resistance was determined by the ratio of 
the I&, values for DNM exhibited by drug-resistant and drug-scnsi- 
live cells. KS, is defined as the concentration of DNM that produces 
50% inhibition of cell growth, upon 48 h incubation of the cells (in log 
phase), in the continuous presence of the drug. 
2.2. It~tracellukw drrcg accwtllrhtion tneasurertlem 
Ccl1 suspensions (10’ cullsln~l) in 10 mM HEPES buffer, pH 7.2, 
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containing 130 mM NaC1, 5 mM KCI, 1.8 mM CaCI, and 1 mM 
MgClz (WBS solution), were incubated with 3 ,uM DNM, in the ab- 
sencc or in the presence of 5 _uM verapnmil (VRP) added to the cells 
2 h prior to the uptake assay. The intracellular level of the anthracy 
cline was estimated under steady-state conditions by flow cytometry 
using an Epics Profile 1 instrument, as previously described [IS]. 
Freeze-fracture plicas of the plasma membrane of P388/S, P388/20 
and P3851100 cells growing in log phase and incubated for 48 h in the 
absence (control) or in the presence of 5 PM of VRP, were obtained 
and analyzed as dcscri bed previously [19. 
3. RESULTS AND DISCUSSION 
Previous reports concerning the characterization of 
the MDR phenotype [l l-141, have described that acqui- 
sition of drug resistance by tumor cells is accompanied 
by marked alterations in the structural organization of 
the plasma membrane. Arsenauit et al. [12] as well as 
Sehested at al. [14’J, found an increase in the density of 
IMPs in the protoplasmic leaflet of the plasma mem- 
brane of drug-resistant sublines compared with wild- 
type cells, which correlated well with the level of overex- 
Table 1 
Number” and sizcb distribution of intramcmbranc particles in plasmn 
membranes from P388 cells 
Intrnmembrane parlicles 
per flm’ 
@388/S P38%/20 P388/lOO 
Control 
Prl~roplciXlric~ fU&e. 
diamctcr c IO nm 
diameter 10-14.9 nm 
diamctur > I5 nm 
Tolal 
E.w~hsn~ic fuce: 
diameter c IO IXI 
diameter 10-14.9 nm 
diameter z I5 nm 
ToKil 
5 yM Verapamil 
Prolopfoumic fuce: 
diamcler c IO nm 
diameter 10-14.9 nm 
diameter > 15 nm 
Total 
E.~ol,lnsi~~ic Jim: 
diameter c IO nm 
diamcur 10-14.9 nm 
diameter > I5 nm 
ToIal 
133f I6 l96+ IS 
785 2 91 1342 f 105* 
208 f 24 306f 24 
I I26 & 131 18441 144’ 
291 8 25?r 3 
1122 29 3962 44’ 
481 12 54* B 
l89t 49 475 f 53 
192f I4 
1421 + lOG* 
3125 23 
1925 * 143* 
21+ 3 
401 f 57” 
482 7 
471 1 67* 
203 f 22 
899 -c 94 
264f 28 
1369 P 143 
32f 8 
155 k 38 
Gl f I5 
248 k 60 
2182 19 221 P 32 
824-r- 71 798 f I17 
298? 26 242 2 36 
1340 f II6 1261 & Ii35 
30-1- 7 29f 6 
108 f 26 98 f 20 
39f 9 91 -1- I9 
177 2 42 218 1: 45 
I’ Each value is the mean f S.E. from 20 culls. For each cell and 
membrane fncc, nt lenst I pm? of membrane nrca were evaluated. 
“The size of the IMPS wasmcasurcd asdescribcd in Ref. 13. Statistical 
evaluation of the data was carried out by analysis of variance for 
muliiplc conipatisons. lndividuol means were compared witin t’nc 
multiple range test of Duncan. A level ofcontidcnceof P c 0.001 was 
sclectcd. 
*Significant differences (P < O.OOl) versus the values of P388/S cells. 
Table I I 
Effect of vcrapamil on the cyrotoxicity induced by DNM in P38X 
leukemia cells 
Vcrapamil (uM) lCW @M DNM) 
P388fS P3l38120 P388/100 
0 0.029 z? 0.003 0.556 f 0.073 2.909 f 0.459 
5 0.040 10.003 0.097 -t- 0.005 0.287 f 0.029 
10 0.035 1 O.OOB 0.050 f 0.009 0.219 * 0.059 
20 0.035 10.004 0.061 f 0.004 0. I52 2 0.049 
pression of P-glycoproteins. Garcia-Segura et al. [13], 
however, reported an almost identical morphological 
alteration in a P388 cell line with a low level of resis- 
tance to DNM, similar to that displayed by the P388120 
ceils, which did not overexpress P-glycoproteins. The 
observations reported here (Fig. I), indicate that the 
changes in the architecture of the plasma membrane in 
the two P388 ceil lines increasingly resistant o DNM, 
seem independent of the level of resistance. Thus, the 
increased number and size distribution of IMPS in these 
two ceil lines are very similar (Table I). The two DNM- 
resistant P388 ceil lines exhibit an approximately 2-fold 
increase in the total number of IMPS with respect o that 
found in the P388/S ceils at both, the P and E faces of 
the plasma membrane. Although the most significant 
increase occurs in the number of IMPS having a diame- 
ter of lo-15 nm, the density of IMPS with lower (C 10 
nm) or larger (3 I5 nm) size, is also increased in the 
DNM-resistant cells. This last point, further emphasizes 
the difficulties in assigning the observed differences in 
size distribution of l.MPs between DNM-sensitive and 
DNM-resistant ceils, to only one molecular entity hav- 
ing a defined molecular size such as the P-glycoprotein 
and rather suggests the occurrence of global changes in 
the architecture of the membranes. 
The most intringuing findings reported in this paper 
concern the effects of a drug resistance-reverting a ent, 
the calcium antagonist VRP . Tsuruo et al. [16] first 
reported that VRP increases the intracellular drug accu- 
mulation in drug-resistant cciis, thus enhancing the sus- 
ceptibility of these cells to the cytotoxic activity of the 
anti-neopiastics, The drug-enhancing activity of VRP 
seems to be independent of its effects on calcium chau- 
nels [17] and it has been suggested to occur mainly by 
competition with antitumor drugs for binding to P- 
glycoproteins [7,8]. In our P388 ceils, VRP at concenlra- 
tions ranging from 5 to 20 /M that do not affect cell 
survival, increases the sensitivity (reduced I&-, values) 
to DNM of the &ug-resistant cells without affecting 
that of the parental, drug-sensitive P3WS cells (Table 
II). Furthermore, as expected from a drug-resistance 
reverting agent, the level of intraceiiuiar accumuiation 
of DNM under steady-state conditions increases ub- 
stantially in the presence of VRP in drug-resistant ceils, 
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Fig. I. Freeze-fracture r plicas of the protoplasmic face of the plasma membrane of P3881S (A,D), P388/2U (B, E) and P388/100 (C.F) cells. A, 
B anu C correspond to plasma mcmbrnnc from cells incubated in the absence of VRP. D, E and F correspond to plasma membranes from cells 
incubated for 48 h in the presence of 5 pM VRP. To avoid possible bias, photographic prints were coded and cvaluatcd without knowledge of 
the experimental group from which pictures were taken. Magnification: 125.000 x. 
remaining nearly unaffected in the case of drug-sensitive 
cells (Fig. 2). It should be noticed, that the effect of VRP 
in increasing both, the sensitivity to DNM and the in- 
tracellular accumulation of the drug, occurs in the two 
P388/100 and P388/20 drug-resistant cell lines. This 
strongly suggests that regardless of the possible occur- 
rence of P-glycoproteins in the P3WlOO cells, the ex- 
pression of which in P388 cells seems to be associated 
with high levels of resistance [18], the mechanism(s) 
through which VRP causes reversion of drug resistance, 
are not neccesarily restricted to the presence of P- 
glycoproteins. In fact, other alterations such as the in- 
tracellular edistribution of anti-neoplastics induced by 
VRP, have also been proposed to explain the reversal 
of MDR by the calcium antagonist [19]. 
Reversion uf DNM-resistance by VRP in P388 cells 
has profounds effects on the ultrastructural organiza- 
tion of the cellular plasma membrane. Fig. lD,E and F 
show that incubation of either P388/20 or P388/100 cells 
with S ,KM VRP, a concentration at which the cells 
retain full proliferative capacity, results in freeze-frac- 
ture images of the plasma membranes from drug-resis- 
tant cells undistinguishable from those of drug-sensitive 
cells (see Table 1 for quantitative analysis of IMPS in the 
freeze-fracture plicas). Sehcsted et al. [14] working on 
cultured Ehrlich ascites tumor cells reported that incu- 
bation with VRP, under different cocditions (higher 
concentrations of VRP and shorter time exposures) to 
those employed in the present study, promoted cluster- 
ing of IMP5 in both drug-sensitive and drug-resistant 
cells. This seems not to be the case for P388 cells since 
as observed in Fig:. 1, all the membrane samples includ- 
ing those exposed to VRP, display a homogeneous dis- 
tribution of IMPS without formation of clusters or 
patches. In a previous study [13], we suggested that the 
different morphology between DNM-resistant and 
DNM-sensitive ceils couid be somehow related to the 
increased plasma membrane traffic in anthracycline-rc- 
sistant P3SS cells reported by Sehcsted and coworkers 
[Xl]. These authors hypothesized that endosomal drug 
trapping followed by vesicular extrusion to the extracel- 
lular medium (the volume and membrane area of en- 
dosomes is higher in anthracycline-resistant than in scn- 
sitive P388 cells), represents a mechanism of Cellular 
drug resistance that -may account for the reduced intra- 
cellular level of anti-neoplastics in drug-resistant cells. 
This possibility seems to be further supported by the 
effects of VRP in restoring the architecture of the 
plasma membranes of DNM-resistant cells, since VRP 
is able to inhibit the increased membrane traffic in these 
cells [20]. 
In summary, oar observations indicate that in addi- 
tion to specific interactions with P-glycoproteins as pro- 
posed by others [7,8], reversion of cellular drug resis- 
tance by verapamil involves global changes affecting the 
assembly and the overall structural organization of the 
membranes. 
d~~trol~h~~c~rterirs: This work was ptrtly supported by grants from 
the DGICYT (PB90-0564) and ihe European Economic Community 
(CT91-0666). F.S. is a predoctoral fellow from the ‘Consejerin de 
Cultura Educaci6n y Ciencia. Gcncralidad Valenchna’. 
~------I REFERENCES 
c] ConLrol 
m 5 /dd YRP 
P380/20 P300/100 
Fig. 2. Total accumulation of DNM by I’388 cells as estimated by laser 
Row cytometry. Cells were incubated with 3yM DNM during 90 min 
(steady-state conditions), in the absence or in the presence of 5 PM 
VRP in I-lUS solur:ion a1 pH 7.2. The Y axis indicates the prrcculagu 
of drug fluorcscencs associated to each cell population. 100% refers 
to the level of lluorcscencc exhibited by drug-sensitive cells. 
bars 2 S.D. 
[I] Escribu. P.V.. Ferrer-Monticl, A.V., Fcrrngut. J.A. and Gon- 
zalcz-Ros, J.M. (1990) Biochemistry 29. 91’75-7282. 
[2] Pctcrson. R.H.F.. Meyers, M.B., Spenglcr. B.A. and Jiedlcr. 
J.L.( 1983) Cancer Res. 43.222-228. 
[3] Ramu, A., Ghubigcr. D.. Magrath. LT. and Joshi. A. (1983) 
Cancer Rcs. 43. 5533-5537. 
[4] Endicott, J.A. and Ling, V. (1989) Annu. Rev. Biochem. 58, 
137-171. 
[5] Hnmada. H. and Tsuruo. T. (1988) J. Biol. Chcm. 2G3, 1454- 
1458. 
[6] Innba, M. And Sakaurni. Y. (1979) C;inwr. Lett. 8. 1 I I-I IS. 
[7] Cornwcll. M.M., Pastan. I. and Gottesmi.m, M.M. (1987) J. Biol. 
Chem. 262,2lGG-2170. 
[S] .%FJ, A.R..Glover. C.J.,Sewell. J.L.. Meyers. M.D., Biedlcr, J.L. 
and Fclstcd. R.L. (1987) J. Biol. Chem. 262. 7884-7888. 
[9] Myers, C., Cowan, K., Sinhn, B. and Chnbnsr, B.. in: Importinn 
advances in Oncology (V.T. DeVita. S. Hellmun and S.A. Rosen- 
bq, Eds.). J.B. tippinco.,. . ,,,.u..r.p...a., . . ., . . DI.:l..Anlnh:n DA !987, pp. 27-38. 
[IO] Tritton, T.R and Posada, J.A.. in: The Role of lhe Cell Surface 
Membrane in Adriamycin Resistance(D. Kcssel, Ed.), Resistance 
lo Antincoplastic Drugs, CRC Press, Florida. pp. 127-139. 
407 
Volume 314. number 3 FEBS LETTERS December 1992 
[II] Wright, L.C., Dyne. M., Holmes, K.T. and Mountford, C.E. 
(19851 Biochem. Bioohvs. Rcs. Commun. 133. 539-545. 
1121 
1131 
[l41 
[ISI 
Arsenault, A.L.. Linb, ‘v. and Kartncr. N. (1988) Biochim. Bio- 
phys. Acta 935, 3 15-321. 
Garcia-Segura. L.M., Fcrragut, J.A., Ferrer-Monticl. A.V.. 
Escribn,P.V. and Gonzalez-Ros. J.M. (1990) Biochim. Biophys. 
Acta 1029, 191-195. 
Schested, M.. Simpson, D.. Skovspurd. T. and Buhl-Jensen, 
P.(l989) Virchows Archiv. B Cell Pathol. 56, 327-335. 
Soto, F., Canttves, J.M., Gonzalez-Ros, J.M. and Ferrag.tt, J.A. 
(1992) FEBS Lett. 301. 119-123. 
1171 
[W 
[l91 
1201 
Tsuruo, T., lida, H,, Yamashiro, M.. Tsukagoshi, S. and Snkurai, 
Y. (1952) Biochcm. Pharmacol. 31, 3138-3140. 
Kc&cl, D. and Wilberding, C. (1985) Cancer Rcs. 45, 1687-1691. 
Kcsscl, D. and Corbctt, T, (1985) Cancer Lett. 28, 157-193. 
Hindenburg, A.A., Baker, M.A., Gleyzer, E., Stewart, V.J.. 
Case,N. and Taub, R.N. (1987) Cancer Res. 47, 1471-1475. 
Sehested, M., Skovsgaard, T., Van Dcurs, B. and Winthcr- 
Nielsen, H. (1987) Br. J. Cancer 56, 747-751. 
408 
